Novartis (NVS)

[whytestocks]

News: $NVS AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)

BASEL, Switzerland , May 24, 2019 /PRNewswire/ --   AveXis, a Novartis company, today announced the US Food and Drug Administration (FDA) has approved Zolgensma ® (onasemnogene abeparvovac-xioi) for the treatment of pediatric patients less than 2 years of age with spinal muscul...

Got this from https://marketwirenews.com/news-releases/avexis-receives-fda-approval-for-zolgensma-xae-the-first-and-only-gene-therapy-for-pediatric-patients-with-spinal-muscular-atrophy-sma--8242944.html